GURUFOCUS.COM » STOCK LIST » Oceania » Australia » ASX » Vectus Biosystems Ltd (ASX:VBS) » Definitions » Accounts Payable
Switch to:

Vectus Biosystems (ASX:VBS) Accounts Payable

: A$0.16 Mil (As of Dec. 2022)
View and export this data going back to 2016. Start your Free Trial

Vectus Biosystems's Accounts Payable for the quarter that ended in Dec. 2022 was A$0.16 Mil.

Vectus Biosystems's quarterly Accounts Payable declined from Dec. 2021 (A$0.76 Mil) to Jun. 2022 (A$0.12 Mil) but then increased from Jun. 2022 (A$0.12 Mil) to Dec. 2022 (A$0.16 Mil).

Vectus Biosystems's annual Accounts Payable declined from Jun. 2020 (A$0.61 Mil) to Jun. 2021 (A$0.33 Mil) and declined from Jun. 2021 (A$0.33 Mil) to Jun. 2022 (A$0.12 Mil).

Vectus Biosystems Accounts Payable Historical Data

The historical data trend for Vectus Biosystems's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Accounts Payable
Premium Member Only Premium Member Only 0.98 1.12 0.61 0.33 0.12

Vectus Biosystems Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
Accounts Payable Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.74 0.33 0.76 0.12 0.16

Vectus Biosystems Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Vectus Biosystems Accounts Payable Related Terms

Thank you for viewing the detailed overview of Vectus Biosystems's Accounts Payable provided by Please click on the following links to see related term pages.

Vectus Biosystems (ASX:VBS) Business Description

Vectus Biosystems logo
Traded in Other Exchanges
3-11 Primrose Avenue, Rosebery, Sydney, NSW, AUS, 2018
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.

Vectus Biosystems (ASX:VBS) Headlines

No Headlines